Alcon (NYSE:ALC) announced today that it launched its Clareon TruPlus intraocular lens (IOL) technology in the U.S.

The new full visual range IOL*1 delivers exceptional distance vision2 and 14% smaller readable print size vs PanOptix3 †. 93% of patients become free from glasses at all distances.#4 ‡ TECNIS Odyssey ...

Please provide your email address to receive an email when new articles are posted on . Multifocal intraocular lenses and accommodating intraocular lenses can be paired with a normal crystalline lens ...

ALC gains after launching Clareon TruPlus IOL, expanding its portfolio with enhanced depth of focus while maintaining high-quality distance vision.

Accommodative IOLs, a new option for lens exchange, are the fastest growing approach to presbyopic IOL use. Although lenses with different mechanisms are in development, the Crystalens IOL (eyeonics, ...

The US Food and Drug Administration (FDA) has approved the Trulign toric posterior chamber intraocular lens (IOL) from Bausch + Lomb, the company announced yesterday. The approval follows a favorable ...

To evaluate the postoperative outcomes of cataract eyes complicated with coexisting ocular pathologies that underwent implantation of a refractive multifocal intraocular lens (MIOL) with a ...

The TECNIS Odyssey IOL addresses a significant unmet need for cataract patients seeking greater spectacle independence. Its ...

"TECNIS Odyssey IOL is the fastest growing PC-IOL in the United States, ^ and we are excited to be making it available to more patients around the world. It addresses a significant unmet need for ...